Publikationen

Hier finden Sie ausgewählte Publikationen zur Dermatologie:

Alrefai H, Muhammad K, Rudolf R, Pham DA, Klein-Hessling S, Patra AK, Avots A, Bukur V, Sa-hin U, Tenzer S, Goebeler M, Kerstan A, Serfling E. (2016) NFATc1 supports imiquimod-induced skin inflammation by suppressingIL-10 synthesis in B cells. Nat Commun 7:11724.

Hesbacher S, Pfitzer L, Wiedorfer K, Angermeyer S, Borst A, Haferkamp S, Scholz CJ, Wobser M, Schrama D, Houben R. (2016) RB1 is the crucial target of the Merkel cell polyomavirus Large T an-tigen in Merkel cell carcinoma cells. Oncotarget 7:32956-32968.

Houben R, Angermeyer S, Haferkamp S, Aue A, Goebeler M, Schrama D, Hesbacher S. (2015) Characterization of functional domains in the Merkel cell polyoma virus Large T antigen. Int J Cancer 136:E290-300.

Karl I, Jossberger-Werner M, Schmidt N, Horn S, Goebeler M, Leverkus M, Wajant H, Giner T. (2014) TRAF2 inhibits TRAIL- and CD95L-indu-ced apoptosis and necroptosis. Cell Death Dis 5:e1444.

Komaravolu RK, Adam C, Moonen JR, Harmsen MC, Goebeler M, Schmidt M. (2015) Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1. Cardiovasc Res 105:86-95.

Publikationen 2018

Adam C, Glück L, Ebert R, Goebeler M, Jakob F, Schmidt M. (2018) The MEK5/ERK5 mitogen-activated protein kinase cascade is an effector pathway of bone-sustaining bisphosphonates that regulates osteogenic differentiation and mineralization. Bone 111, 49-58.

Baur J, Mathe K, Gesierich A, Weyandt G, Wiegering A, Germer CT, Pelz JOW. Impact of extended lymphadenectomy on morbidity and regional recurrence-free survival in melanoma patients. J Dermatolog Treat Nov 16:1-7. doi: 10.1080/09546634.2017.1398395.

Becker JC, Stang A, Hausen AZ, Fischer N, DeCaprio JA, Tothill RW, Lyngaa R, Hansen UK, Ritter C, Nghiem P, Bichakjian CK, Ugurel S, Schrama D. (2018) Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC. Cancer Immunol Immunother 67, 341-351.

Benoit S, Scheurlen M, Goebeler M, Stoevesandt J. (2018) Structured Diagnostic Approach and Risk Assessment in Mucous Membrane Pemphigoid with Oesophageal Involvement. Acta Derm Venereol 98, 660-666.

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R. (2018) S2k Guidelines -Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86). J Dtsch Dermatol Ges 16, 112-122.

Fattouh K, Cunha N, Frings V, Hernandez-Aragues I, Stembridge N, Kuonen F. (2018) What's new this month? Eur J Dermatol 28, 134-135.

Frings A, Frings V, Geerling G, Goebeler M, Schargus M. (2018) Progrediente Ulzeration der Periorbita. Ophthalmologe 115, 157-160.

Frings V, Fattouh K, Hernandez Aragues I, Cunha N, Stembridge N, Kuonen F. (2018) What’s new this month? Eur J Dermatol 28, 278-279.

Frings VG, Böer-Auer A, Breuer K. (2018) Histomorphology and Immunophenotype of Eczematous Skin Lesions Revisited-Skin Biopsies Are Not Reliable in Differentiating Allergic Contact Dermatitis, Irritant Contact Dermatitis, and Atopic Dermatitis. Am J Dermatopathol 40, 7-16.

Frings VG, Schäfer K, Strate A, Rosenwald A, Roth S, Kneitz H, Goebeler M, Geissinger E, Wobser M. Paraproteinaemia in primary cutaneous marginal zone lymphoma. Acta Derm Venereol (2018, in press).

Glossmann JP, Skoetz N, Starbatty B, Bischoff M, Leyvraz S, Westekemper H; AG SOP; Unter-AG Konjunktivales Melanom, Heindl LM (Collaborators: u. a. Gesierich A). Conjunctival melanoma: Standard operating procedures in diagnosis, treatment and follow-up care. Ophthalmologe (2018) in press.

Glutsch V, Gesierich A, Goebeler M, Forster J, Schilling B. Nocardiosis in a patient with with anti-PD-1-associated colitis treated with imnfliximab. Eur J Cancer (2018, in press).

Grän F, Schwaneck EC, Rehn M, Strate A, Goebeler M, Benoit S. (2018) Kinderwunsch bei Lupus erythematodes – eine medizinische Herausforderung. J Dtsch Dermatol Ges 16, 913-916.

Haug V, Behle V, Benoit S, Kneitz H, Schilling B, Goebeler M, Gesierich G. Pembrolizumab-associated Mucous Membrane Pemphigoid in a Merkel cell carcinoma patient. Brit J Dermatol (2018, in press).

Haug V, Schilling B. PD-1 blockade for multiple basal cell carcinomas: Clearing the field systemically? (Commentary on "Effective anti-PD-1 therapy in a SUFU-mutated patient with Gorlin-Goltz Syndrome" by A. Moreira et al.) Brit J Dermatol (2018, in press).

Heratizadeh A , Werfel T , Schubert S , Geier J ; IVDK ( Collaborators: u. a. Trautmann A). (2018) Contact sensitization in dental technicians with occupational contact dermatitis. Data of the Information Network of Departments of Dermatology (IVDK) 2001-2015. Contact Dermatitis 78, 266-273.

Holtsche MM, Goletz S, van Beek N, Zillikens D, Benoit S, Harman K, Walton S, English J, Sticherling M, Chapman A, Levell NJ, Groves R, Williams HC, König IR, Schmidt E; BLISTER Study Group. Prospective study in bullous pemphigoid: Association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score. Br J Dermatol (2018) in press.

Kähler KC, Eigentler TK, Gesierich A, Heinzerling L, Loquai C, Meier F, Meiss F, Pföhler C, Schlaak M, Terheyden P, Thoms KM, Ziemer M, Zimmer L, Gutzmer R; German Dermatologic Cooperative Oncology Group (DeCOG). (2018) Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders. Cancer Immunol Immunother 67, 825-834.

Kervarrec T, Gaboriaud P, Berthon P, Zaragoza J, Schrama D, Houben R, Le Corre Y, Hainaut Wierzbicka E, Aubin F, Bens G, Domenech J, Guyétant S, Touzé A, Samimi M. (2018) Merkel cell carcinomas infiltrated with CD33+ myeloid cells and CD8+ T cells are associated with improved outcome. J Am Acad Dermatol. 78, 973-982.e8.

Kervarrec T, Samimi M, Gaboriaud P, Gheit T, Beby-Defaux A, Houben R, Schrama D, Fromont G, Tommasino M, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, Bens G, Maillard H, Furudoï A, Michenet P, Touzé A, Guyétant S. (2018) Detection of the Merkel cell polyomavirus in the neuroendocrine component of combined Merkel cell carcinoma. Virchows Arch 472, 825-837.

Kirchberger MC, Schilling B, Haferkamp S, Bosserhoff A, Schuler G, Heinzerling L. (2018) Can checkpoint inhibitor therapy improve response to chemotherapy? J Cancer Res Clin Oncol 144, 183-185.

Kneitz H, Fetzer S, Goebeler M, Bröcker EB. (2018) Differenzialdiagnostische Bedeutung epithelialer und stromaler CD10-Expression in Tumoren trichogenen Ursprungs. J Dtsch Dermatol Ges 16, 719-729.

Kugel CH, Douglass SM, Webster MR, Kaur A, Liu Q, Yin X, Weiss SA, Darvishian F, Al-Rohil RN, Ndoye A, Behera R, Alicea GM, Ecker BL, Fane M, Allegrezza MJ, Svoronos N, Kumar V, Wang DY, Somasundaram R, Hu-Lieskovan S, Ozgun A, Herlyn M, Conejo-Garcia JR, Gabrilovich D, Stone EL, Nowicki TS, Sosman J, Rai R, Carlino MS, Long GV, Marais R, Ribas A, Eroglu Z, Davies MA, Schilling B, Schadendorf D, Xu W, Amaravadi RK, Menzies AM, McQuade JL, Johnson DB, Osman I, Weeraratna AT. Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations. Clin Cancer Res (2018, in press) DOI: 10.1158/1078-0432.CCR-18-1116.

Maurus K, Appenzeller S, Roth S, Kuper J, Rost S, Meierjohann S, Arampatzi P, Goebeler M, Rosenwald A, Geissinger E, Wobser M. (2018) Panel Sequencing Reveals Recurrent Genetic FAS Alterations. In Primary Cutaneous Marginal Zone Lymphoma. J Invest Dermatol 138, 1573-1581.

Miao D, Margolis CA, Vokes NI, Liu D, Taylor-Weiner A, Wankowicz SM; Adeegbe D, Keliher D, Schilling B, Tracy A, Manos M, Chau NG, Hanna GJ, Polak P, Rodig SJ, Signoretti S, Sholl LM; Engelman JA, Getz G, Jänne PA, Haddad RI, Choueiri TK, Barbie DA; Haq R, Awad MM; Schadendorf D, Hodi FS, Bellmunt J, Wong KK; Hammerman P, Van Allen EM. Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors. Nature Genet (2018, in press).

Milsch L, Gesierich A, Kreft S, Livingstone E, Zimmer L, Goebeler M, Schadendorf D, Schilling B. (2018) Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade. Eur J Cancer 99, 58-65.

Schäfer K, Cotofana S, Goebeler M, Weyandt G. Large nasal defects with exposed cartilage: The folded transposition flap. Dermatology (2018, in press).

Schmid C, Reichel A, Kerstan A, Gesierich A, Hamm H. (2018) Slate-gray macules in the axillae. Hautarzt 69, 177-179.

Schmidt M, Goebeler M. (2018) Innate Immune System response in Metal Allergy: Toll-Like Receptors. In: Chen JK, Thyssen J (Hrg.): Metal Allergy. From Dermatitis to Implant and device Failure. Springer-Verlag, Berlin-Heidelberg-New York S. 75-84.

Scholz S, Cosgarea I, Süßkind D, Murali R, Reis H, Leonardelli S, Schilling B, Schimming T, Hadaschik E, Franklin C, Paschen A, Sucker S, Steuhl KP, Schadendorf D, Westekemper H, Griewank K, Möller I. (2018) NF1 mutations in conjunctival melanoma. Brit J Cancer 118, 1243-1247.

Shukla SA, Bachireddy P, Schilling B, Galonska C, Zhan Q, Bango C, Langer R, Lee PC, Gusenleitner D, Keskin DB, Babadi M, Mohammad A, Gnirke A, Clement K, Cartun ZJ, Van Allen EM, Miao D, Huang Y, Snyder A, Merghoub T, Wolchok JD, Garraway LA, Meissner A, Weber JS, Hacohen N, Neuberg D, Potts PR, Murphy GF, Lian CG, Schadendorf D, Hodi FS, Wu CJ. (2018) Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade. Cell 173, 624-633.e8.

Stoevesandt J, Trautmann A. Freshly squeezed: anaphylaxis caused by drone larvae juice. Eur Ann Allergy Clin Immunol. 2017 Nov 30. doi: 10.23822/EurAnnACI.1764-1489.43.

Stolze I, Hamm H. Lichen nitidus and lichen striatus. Hautarzt 69, 121-126.

Teramoto Y, Keim U, Gesierich A, Schuler G, Fiedler E, Tüting T, Ulrich C, Wollina U, Hassel JC, Gutzmer R, Goerdt S, Zouboulis C, Leiter U, Eigentler TK, Garbe C. (2018) Acral lentiginous melanoma - a skin cancer with unfavourable prognostic features. A study of the German Central Malignant Melanoma Registry (CMMR) in 2050 patients. Brit J Dermatol 178, 443-451.

Thiem A, Schummer P, Ueberschaar S, Kerstan A, Kneitz H, Schrama D, Appenzeller S, Meierjohann S, Schilling B, Goebeler M, Gesierich A. Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors. Melanoma Res (2018) in press.

Trautmann A, Goebeler M, Stoevesandt J. Twenty years' experience with anaphylaxis-like reactions to local anesthetics: genuine allergy is rare. J Allergy Clin Immunol Pract 2018 (in press).

Vogt T, Goebeler M. (2018) Lichenoid diseases. Hautarzt 69, 98-99.

Publikationen 2017

Adam C, Wohlfarth J, Haußmann M, Sennefelder H, Rodin A, Maler M, Martin SF, Goebeler M, Schmidt M. (2017) Allergy-inducing chromium compounds trigger potent innate immune stimulation via ROS-dependent inflammasome activation. J Invest Dermatol 137:367-376.

Baur J, Mathe K, Gesierich A, Weyandt G, Wiegering A, Germer CT, Gasser M, Pelz JOW. (2017) Morbidity and oncologic outcome after saphenous vein-sparing inguinal lymphadenectomy in melanoma patients. World J Surg Oncol 15:99.

Baur J, Mathe K, Gesierich A, Weyandt G, Wiegering A, Germer CT, Pelz JOW. (2017) Impact of extended lymphadenectomy on morbidity and regional recurrence-free survival in melanoma patients. J Dermatolog Treat 16:1-7. doi: 10.1080/09546634.2017.1398395.

Becker JC, Lorenz E, Ugurel S, Eigentler TK, Kiecker F, Pföhler C, Kellner I, Meier F, Kähler K, Mohr P, Berking C, Haas G, Helwig C, Oksen D, Schadendorf D, Mahnke L, Bharmal M. (2017) Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe. Oncotarget 8(45):79731-79741 doi: 10.18632/oncotarget.19218.

Behle V, von Braunmühl T, Sayehli C, Gesierich A, Goebeler M, Geissinger E, Wobser M. (2017) Sézary Syndrome with Nodal CD30-positive Manifestation Treated with Brentuximab Vedotin and Extracorporeal Photopheresis. Acta Derm Venereol 97:973-975.

Borst A, Haferkamp S, Grimm J, Rösch M, Zhu G, Guo S, Li C, Gao T, Meierjohann S, Schrama D, Houben R. (2017 in press) BIK is involved in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines. Cancer Letters Letters 404, 70-78.

Cunha N, Fattouh K, Frings V, Hernandez-Aragues I, Stembridge N, Kuonen F. (2017) What’s new this month? Eur J Dermatol 27, 678-679.

Cunha N, Stembridge N, Frings V, Fattouh K, Hernandez-Aragues I, Kuonen F. (2017) Editorial: What's new this month? Eur J Dermatol 27:446-447.

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R. (2017) S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86). J Dtsch Dermatol Ges 15, 1266-1273.

Dogliotti G, Kullmann L, Dhumale P, Thiele C, Panichkina O, Mendl G, Houben R, Haferkamp S, Püschel AW, Krahn MP. (2017) Membrane-binding and activation of LKB1 by phosphatidic acid is essential for development and tumour suppression. Nat Commun 8:15747 doi:10.1038/ncomms15747.

Franklin C, Rooms I, Fiedler M, Reis H, Milsch L, Herz S, Livingstone E, Zimmer L, Schmid KW, Dittmer U, Schadendorf D, Schilling B. (2017) Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis. Eur J Cancer 86:248-256.

Frings A, Frings V, Geerling G, Goebeler M, Schargus M. (2017, in press) Progrediente Ulzeration der Periorbita. Ophthalmologe, doi:10.1007/s00347-017-0512-0.

Frings V, Fattouh K, Hernandez-Aragues I, Cunha N, Stembridge N, Kuonen F. (2017) Editorial: What's new this month? Eur J Dermatol 27:214-215.

Frings VG, Böer-Auer A, Breuer K. (2017, in press) Histomorphology and Immunophenotype of Eczematous Skin Lesions Revisited-Skin Biopsies Are Not Reliable in Differentiating Allergic Contact Dermatitis, Irritant Contact Dermatitis, and Atopic Dermatitis. Am J Dermatopathol.

Frings VG, Goebeler M, Kneitz H. (2017) Dermpath & Clinic: Giant trichoblastoma of the leg. Eur J Dermatol 27:447-448.

Frings VG, Hamm H. (2017) Dermatologische Manifestationen der tuberösen Sklerose (TSC) (Leserbrief zu Ebrahimi-Fakhari D et al., J Dtsch Dermatol Ges 15:695-701). J Dtsch Dermatol Ges 15:1155-1156.

Frings VG, Roth S, Riedmiller AL, Schäfer K, Goebeler M, Rosenwald A, Geissinger E, Wobser M. (2017) Primary Cutaneous T-cell Lymphoma with Aberrant Expression of CD20. Acta Derm Venereol 97:534-536.

Frings VG, Trautmann A, Goebeler M, Wobser M. (2017) Dermpath & Clinic: Multiple reactive eccrine syringofibroadenomas. Eur J Dermatol 27:102-104.

Gassenmaier M, Eigentler TK, Keim U, Goebeler M, Eckhard Fiedler E, Gerold Schuler G, Ulrike Leiter U, Weide B, Grischke EM, Martus P, Garbe C. (2017) Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry. J Invest Dermatol 137:2570-2577.

Giner T, Benoit S, Kneitz H, Goebeler M. (2017, in press) Sarkoidose – der dermatologische Blick auf eine seltene Multisystemerkrankung. Hautarzt 68, 526-535.

Griewank KG, Müller H, Jackett LA, Emberger M, Möller I, van de Nes JA, Zimmer L, Livingstone E, Wiesner T, Scholz SL, Cosgarea I, Sucker A, Schimming T, Hillen U, Schilling B, Paschen A, Reis H, Mentzel T, Kutzner H, Rütten A, Murali R, Scolyer RA, Schadendorf D. (2017, in press) SF3B1 and BAP1 mutations in blue nevus-like melanoma. Mod Pathol 30, 928-939.

Griewank KG, Paschen A. (2017) Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions. Nat Commun 8:15440 doi:10.1038/ncomms15440.

Gutzmer R, Koop A, Meier F, Hassel JC, Terheyden P, Zimmer L, Heinzerling L, Ugurel S, Pföhler C, Gesierich A, Livingstone E, Satzger I, Kähler KC; German Dermatooncology Group (DeCOG). (2017) Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity. Eur J Cancer 75:24-32.

Hamm H. (2017) Krätzealarm im Altenheim. MMW Fortschr Med 159:22.

Haug V, Benoit S, Wohlleben M, Hamm H. (2017, in press) Annular pustular psoriasis in a 14-month-old girl: a therapeutic challenge. J Dermatolog Treat 28, 520-522.

Haymerle G, Janik S, Fochtmann A, Pammer J, Schachner H, Nemec L, Mildner M, Houben R, Grasl MC, Erovic BM. (2017) Expression of Merkel cell polyomavirus (MCPyV) large T-antigen in Merkel cell carcinoma lymph node metastases predicts poor outcome. PLoS One Aug 1;12(8):e0180426. doi: 10.1371/journal.pone.0180426.

Helbig D, Quaas A, Mauch C, Merkelbach-Bruse S, Büttner R, Emberger M, Wobser M, Rüsseler V, Pütz K, Binot E, Rehker J, Budczies J, Ihle MA. (2017) Copy number variations in atypical fibroxanthomas and pleomorphic dermal sarcomas. Oncotarget 8:109457-109467.

Heppt MV, Siepmann T, Engel J, Schubert-Fritschle G, Eckel R, Mirlach L, Kirchner T, Jung A, Gesierich A, Ruzicka T, Flaig MJ, Berking C. (2017) Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care. BMC Cancer Aug 10;17(1):536. doi: 10.1186/s12885-017-3529-5.

Heppt MV, Roesch A, Weide B, Gutzmer R, Meier F, Loquai C, Kähler KC, Gesierich A, Meissner M, von Bubnoff D, Göppner D, Schlaak M, Pföhler C, Utikal J, Heinzerling L, Cosgarea I, Engel J, Eckel R, Martens A, Mirlach L, Satzger I, Schubert-Fritschle G, Tietze JK, Berking C. (2017) Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur J Cancer 81:36-44.

Hernandez-Aragues I, Cunha N, Fattouh K, Frings V, Stembridge N, Kuonen F. (2017) What's new this month? Eur J Dermatol 27:335-336.

Hosp C, Hamm H. (2017, in press) Safety of available and emerging drug therapies for hyperhidrosis. Exp Opin Drug Safety 16, 1039-1049.

Improta G, Ritter C, Pettinato A, Vasta V, Schrama D, Fraggetta F, Becker JC. (2017, in press) MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus in vivo. J Cancer Res Clin Oncol 143, 1489-1497.

Khalil AA, Ilina O, Gritsenko PG, Bult P, Span PN, Friedl P. (2017) Collective invasion in ductal and lobular breast cancer associates with distant metastasis. Clin Exp Metastasis 34:421-429.

M.B. Faries, J.F. Thompson, A.J. Cochran, R.H. Andtbacka, N. Mozzillo, J.S. Zager, T. Jahkola, T.L. Bowles, A. Testori, P.D. Beitsch, H.J. Hoekstra, M. Moncrieff, C. Ingvar, M.W.J.M. Wouters, M.S. Sabel, E.A. Levine, D. Agnese, M. Henderson, R. Dummer, C.R. Rossi, R.I. Neves, S.D. Trocha, F. Wright, D.R. Byrd, M. Matter, E. Hsueh, A. MacKenzieRoss, D.B. Johnson, P. Terheyden, A.C. Berger, T.L. Huston, J.D. Wayne, B.M. Smithers, H.B. Neuman, S. Schneebaum, J.E. Gershenwald, C.E. Ariyan, D.C. Desai, L. Jacobs, K.M. McMasters, A. Gesierich, P. Hersey, S.D. Bines, J.M. Kane, R.J. Barth, G. McKinnon, J.M. Farma, E. Schultz, S. Vidal‐Sicart, R.A. Hoefer, J.M. Lewis, R. Scheri, M.C. Kelley, O.E. Nieweg, R.D. Noyes, D.S.B. Hoon, H. J. Wang, D.A. Elashoff, and R.M. Elashoff. (2017) Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. New Engl J Med 376:2211-2222.

Mergler R, Kerstan A, Schmidt E, Goebeler M, Benoit S. (2017) Atypical clinical and serological manifestation of pemphigus vegetans: a case report and review of the literature. Case Rep Dermatol 9:121–130.

Mindorf S, Dettmann IM, Krüger S, Fuhrmann T, Rentzsch K, Karl I, Probst C, Komorowski L, Fechner K, van Beek N, Lemcke S, Sárdy M, Bangert C, Benoit S, Hashimoto T, Zillikens D, Pas HH, Jonkman MF, Stöcker W, Schmidt E, International Autoimmune Bullous Diseases Study Group. (2017) Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical Pemphigus. Exp Dermatol 26:1267-1270.

Müller-Richter UDA, Gesierich A, Kübler AC, Hartmann S, Brands RC. (2017) Merkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment. Ann Surg Oncol 24:3430-3427.

Ofner R, Ritter C, Heidenreich B, Kumar R, Ugurel S, Schrama D, Becker JC. (2017) Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients. J Cancer Res Clin Oncol 143:613-617.

Ofner R, Ritter C, Ugurel S, Cerroni L, Stiller M, Bogenrieder T, Solca F, Schrama D, Becker JC. (2017) Non-reproducible sequence artifacts in FFPE tissue: an experience Report. J Cancer Res Clin Oncol 143:1199-1207.

Oji V, Preil ML, Kleinow B, Wehr G, Fischer J, Hennies HC, Hausser I, Breitkreutz D, Aufenvenne K, Stieler K, Tantcheva-Poór I, Weidinger S, Emmert S, Hamm H, Perusquia-Ortiz AM, Zaraeva I, Diem A, Giehl K, Fölster-Holst R, Kiekbusch K, Höger P, Ott H, Traupe H. (2017) S1 guidelines for the diagnosis and treatment of ichthyoses – update. J Dtsch Dermatol Ges 15:1053-1065.

Papapanagiotou M, Griewank KG, Hillen U, Schimming TT, Moeller LC, Führer D, Zimmer L, Roesch A, Sucker A, Schadendorf D, Livingstone E, Schilling B. (2017) Trametinib-Induced Remission of an MEK1-Mutated Langerhans Cell Histiocytosis. JCO Precision Oncology doi: 10.1200/PO.16.00070.

Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M2 and the ALCANZA study group (Collaborators: Trotman J, Joske D, Prince HM, Taylor K, Lewis ID, Jonak C, Trautinger F, Bechter O, Wolter P, Bron D, de Lima VCC, Sanches JA Junior, Klasa R, Bagot M, Beylot-Barry M, Dalle S, D'Incan M, Dreno B, Grange F, Nicolay J, Stadler R, Weichenthal M, Wobser M, Assaf C, Loquai C, Quaglino P, Spina M, Zinzani PL, Bosi A, Fattori PP, Grzanka A, Walewski J, Lopez-Hernandez A, Ortiz-Romero PL, Roca JJR, Canales SN, Dummer R, Illidge T, Johnson R, Whittaker S, Morris S, McKay P, Scarisbrick J, Duvic M, Feldman T, Akilov O, Geskin L, Horwitz S, Kim YH, Pro B, Kuzel T, Lerner A, Eradat H, Sokol L, Fisher DC, Hughey S). (2017) Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet 390:555-566.

Reichel A, Benoit S, Giner T, Schmidt E, Goebeler M, Stoevesandt J. (2017) Anti-Desmoglein 1 IgG/IgA-Pemphigus in Verbindung mit einem Thymom. J Dtsch Dermatol Ges 15:1147-1149.

Reichel A, Hamm H, Wiegering V, Wiewrodt B, Neubauer H, Ernestus K, Winkler B. (2017) Kaposiformes Hämangioendotheliom mit Kasabach-Merritt-Syndrom: erfolgreiche Therapie mit Sirolimus. J Dtsch Dermatol Ges 15:329-331.

Ritter C, Fan K, Paschen A, Reker Hardrup S, Ferrone S, Nghiem P, Ugurel S, Schrama D, Becker JC. (2017) Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma. Sci Rep 7(1):2290. doi:10.1038/s41598-017-02608-0.

Sadik CD, Bischof J, van Beek N, Dieterich A, Benoit S, Sárdy M, Worm M, Meller S, Gläser R, Zillikens D, Homey B, Setterfield J, Minassian D, Schmidt E, Dart J; MMP study group 2009 - 2014; Autoimmune Bullous Diseases Study Group, Ibrahim SM. (2017) Genome-wide association study identifies GALC as susceptibility gene for mucous membrane pemphigoid. Exp Dermatol 26:2014-2020.

Sadik CD, Pas HH, Bohlmann MK, Mousavi S, Benoit S, Sárdy M, Terra JB, Lima AL, Hammers CM, van Beek N, Bangert C, Zillikens D, Schmidt E. (2017) Value of BIOCHIP Technology in the Serological Diagnosis of Pemphigoid Gestationis. Acta Derm Venereol 97:128-130.

Schäfer K, Bauer B, Donhauser J, Kerstan A, Hamm H. (2017) Becker Naevus Syndrome of the Lower Body: One Case and Review of the Literature. Acta Derm Venereol 97:499-504.

Schmidt E, Benoit S, Kampik D, Hille K, Geerling G. (2017) Tibial bone keratoprosthesis: reversing blindness in mucous membrane pemphigoid. J Dtsch Dermatol Ges 15:1024-1026.

Schmidt T, Hoch M, Lotfi Jad SS, Solimani F, Di Zenzo G, Marzano AV, Goebeler M, Cozzani E, Kern JS, Sitaru C, Lakoš Jukić I, Sárdy M, Uzun S, Jedlickova H, Gläser R, Kaneda M, Eming R, Göpel G, Ishii N, Greene B, Hashimoto T, Hertl M. (2017, in press) Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita - a multicenter analysis. Brit J Dermatol.

Schmidt T, Hoch M, Lotfi Jad SS, Solimani F, Di Zenzo G, Marzano AV, Goebeler M, Cozzani E, Kern JS, Sitaru C, Lakoš Jukić I, Sárdy M, Uzun S, Jedlickova H, Gläser R, Kaneda M, Eming R, Göpel G, Ishii N, Greene B, Hashimoto T, Hertl M. (2017) Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita - a multicenter analysis. Brit J Dermatol 177, 1683-1692.

Scholz SL, Möller I, Reis H, Süßkind D, van de Nes JAP, Leonardelli S, Schilling B, Livingstone E, Schimming T, Paschen A, Sucker A, Murali R, Steuhl KP, Schadendorf D, Westekemper H, Griewank KG. (2017) Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma. Invest Ophthalmol Vis Sci 58:3464-3470.

Schrama D, Ritter C, Becker JC. (2017) T cell receptor repertoire usage in cancer as a surrogate marker for immune Responses. Semin Immunopathol 39:255-268.

Sekulic A, Migden MR, Basset-Seguin N, Garbe C, Gesierich A, Lao CD, Miller C, Mortier L, Murrell DF, Hamid O, Quevedo JF, Hou J, McKenna E, Dimier N, Williams S, Schadendorf D, Hauschild A; ERIVANCE BCC Investigators. (2017) Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study. BMC Cancer 17, 332. doi:10.1186/s12885-017-3286-5.

Stembridge N, Cunha N, Frings V, Fattouh K, Hernandez-Aragues I, Kuonen F. (2017)Editorial: What's new this month? Eur J Dermatol 27:565-566.

Sticherling M, Franke A, Aberer E, Gläser R, Hertl M, Pfeiffer C, Rzany B, Schneider S, Shimanovich I, Werfel T, Wilczek A, Zillikens D, Schmidt A. (2017) An open, multicenter, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone. Brit J Dermatol 177:1299-1305.

Stoevesandt J, Hosp C, Kerstan A, Trautmann A. (2017) Safety of 100 µg venom immunotherapy rush protocols in children compared to adults. Allergy Asthma Clin Immunol 13:32 doi: 10.1186/s13223-017-0204-y.

Sucker A, Zhao F, Pieper N, Heeke C, Maltaner R, Stadtler N, Real B, Bielefeld N, Howe S, Weide B, Gutzmer R, Utikal J, Loquai C, Gogas H, Klein-Hitpass L, Zeschnigk M, Westendorf AM, Trilling M, Horn S, Schilling B, Schadendorf D, Griewank KG, Paschen A. (2017) Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions. Nat Commun 8:15440 doi:10.1038/ncomms1544.

Teramoto Y, Keim U, Gesierich A, Schuler G, Fiedler E, Tüting T, Ulrich C, Wollina U, Hassel JC, Gutzmer R, Goerdt S, Zouboulis C, Leiter U, Eigentler TK, Garbe C. (2017, in press) Acral lentiginous melanoma - a skin cancer with unfavourable prognostic features. A study of the German Central Malignant Melanoma Registry (CMMR) in 2050 patients. Brit J Dermatol.

Thiem A, Kneitz H, Schummer P, Herz S, Schrama D, Houben R, Goebeler M, Schilling B, Gesierich A. (2017) Coincident metastatic melanoma and Merkel cell carcinoma with complete remission upon treatment with pembrolizumab. Acta Derm Venereol 97:1252-125.

Toksoy A, Sennefelder H, Adam C, Hofmann S, Trautmann A, Goebeler M, Schmidt M. (2017) Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir. J Biol Chem 292:2805-2814.

Toksoy A, Strifler S, Benoit S, Grigoleit GU, Knop S, Mielke S, Buder-Bakhaya K, Roth S, Goebeler M, Rosenwald A, Geissinger E, Wobser M. (2017) Facial Swelling and Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr Virus-associated T-cell Lymphoproliferation with Subsequent Development of Lymphoma. Acta Derm Venereol 97:379-380.

Trautmann A, Benoit S, Goebeler M, Stoevesandt J. (2017, in press) "Treating Through" Decision and Follow-up in Antibiotic Therapy-Associated Exanthemas. J Allergy Clin Immunol Pract 5, 1650-1656.

Trautmann A, Stoevesandt J. (2017) Reply. J Allergy Clin Immunol Pract 5, 535-536.

Ugurel S, Loquai C, Terheyden P, Schadendorf D, Richtig E, Utikal J, Gutzmer R, Rass K, Sunderkötter C, Stein A, Fluck M, Kaatz M, Trefzer U, Kähler K, Stadler R, Berking C, Höller C, Kerschke L, Edler L, Kopp-Schneider A, Becker JC. (2017) Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial. Oncotarget 8:76029-76043 doi: 10.18632/oncotarget. 18635.

Walter E, Vielmuth F, Rotkopf L, Sárdy M, Horváth ON, Goebeler M, Schmidt E, Eming R, Hertl M, Spindler V, Waschke J. (2017) Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus. Sci Rep 7(1):3579. doi:10.1038/s41598-017-03697-7.

Williams HC, Wojnarowska F, Kirtschig G, Mason J, Godec TR, Schmidt E, Chalmers JR, Childs M, Walton S, Harman K, Chapman A, Whitham D, Nunn AJ; UK Dermatology Clinical Trials Network BLISTER Study Group (Collaborators: u. a. Bröcker EB). (2017) Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled Trial. Lancet 389:1630-1638.

Wobser M, Maurus K, Roth S, Appenzeller S, Weyandt G, Goebeler M, Rosenwald A, Geissinger E. (2017) MYD88 mutations in a distinct type of cutaneous marginal zone lymphoma with a non-class switched IgM-immunophenotype. Br J Dermatol 177:564-566.

Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, Ingram JR, Kanni T, Karagiannidis I, Martorell A, Matusiak L, Pinter A, Prens EP, Presser D, Schneider-Burrus S, von Stebut E, Szepietowski JC, van der Zee HH, Wilden SM, Sabat R on behalf oft he EHSF Investigator Group. (2017) Development and validation of IHS4, a novel dynamic scoring system to assess hidradenitis suppurativa/acne inversa severity. Br J Dermatol 177:1401-1409.

 

 

Publikationen 2016

Almanzar G, Klein M, Schmalzing M, Hilligardt D, El Hajj N, Kneitz H, Wild V, Rosenwald A, Benoit S, Hamm H, Tony HP, Haaf T, Goebeler M, Prelog M. (2016) Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis. Int Arch Allergy Immunol 171:141-154.

Alrefai H, Muhammad K, Rudolf R, Pham DA, Klein-Hessling S, Patra AK, Avots A, Bukur V, Sahin U, Tenzer S, Goebeler M, Kerstan A, Serfling E. (2016) NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells. Nat Commun 7:11724.

Basmanav FB, Cau L, Tafazzoli A, Méchin MC, Wolf S, Romano MT, Valentin F, Wiegmann H, Huchenq A, Kandil R, Garcia Bartels N, Kilic A, George S, Ralser DJ, Bergner S, Ferguson DJ, Oprisoreanu AM, Wehner M, Thiele H, Altmüller J, Nürnberg P, Swan D, Houniet D, Büchner A, Weibel L, Wagner N, Grimalt R, Bygum A, Serre G, Blume-Peytavi U, Sprecher E, Schoch S, Oji V, Hamm H, Farrant P, Simon M, Betz RC. (2016) Mutations in Three Genes Encoding Proteins Involved in Hair Shaft Formation Cause Uncombable Hair Syndrome. Am J Hum Genet 99:1292-1304.

Behle V, Goebeler M, Gesierich A. (2016) Seriously saRComa: Neurofibrosarcoma. Eur J Dermatol 26:517-518.

Behle V, Wobser M, Goebeler M, Stoevesandt J. (2016) Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod. Mult Scler 22:969-71.

Bluemel C, Safak G, Cramer A, Wöckel A, Gesierich A, Hartmann E, Schmid JS, Kaiser F, Buck AK, Herrmann K. (2016) Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodes. Eur J Nucl Med Mol Imaging 43:2304-2312.

Bröcker E, Gollnick H, Goerdt S, Malte-Baron J. (2016) Obituary: Professor Martin Leverkus: 1965-2016. Br J Dermatol 174:1424-1245.

Bröcker E, Gollnick H, Goerdt S, Baron JM. (2016) Martin Leverkus – Nachruf. J Dtsch Dermatol Ges 14:459-61.

Dieckmann R, Boone I, Brockmann SO, Hammerl JA, Kolb-Mäurer A, Goebeler M, Luch A, Dahouk SA. (2016) Risiken für bakterielle Infektionen nach Tätowierungen. Ein systematisches Literaturreview. Dtsch Arztebl Int 113:665-71.

Ellerbroek V, Hamm H. (2016) Pityriasis Lichenoides et Varioliformis Acuta: Remission with Hypopigmentation. J Pediatr 176:211.

Hamm H. (2016) Kinderdermatologie: ein Kleinod unseres Fachgebiets. J Dtsch Dermatol Ges 14:345-6.

Hamm H. (2016) Severely impaired quality of life. "My sweating is intolerable.". MMW Fortschr Med 158:46-50.

Hesbacher S, Pfitzer L, Wiedorfer K, Angermeyer S, Borst A, Haferkamp S, Scholz CJ, Wobser M,  Schrama D, Houben R. (2016, in press) RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells. Oncotarget.

Hofmann L, Forschner A, Loquai C, Goldinger SM, Zimmer L, Ugurel S, Schmidgen MI, Gutzmer R, Utikal JS, Göppner D, Hassel JC, Meier F, Tietze JK, Thomas J, Weishaupt C, Leverkus M, Wahl R, Dietrich U, Garbe C, Kirchberger MC, Eigentler T, Berking C, Gesierich A, Krackhardt AM, Schadendorf D, Schuler G, Dummer R, Heinzerling LM. (2016) Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy. Eur J Cancer 60:190-209.

Hosp C, Naumann MK, Hamm H. (2016) Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea. Semin Neurol 36:20-8.

Karademir F, Rose C, Goebeler M, Kneitz H, Hamm H, Wobser M. (2016) Multiple eruptive Angiofibrome bei einem 14-jährigen Mädchen. J Dtsch Dermatol Ges 14:746-748.

Klein M, Schmalzing M, Almanzar G, Benoit S, Hamm H, Tony HP, Goebeler M, Prelog M. (2016) Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc). Autoimmunity 25:1-15.

Lange J, Weil F, Riegler C, Groeber F, Rebhan S, Kurdyn S, Alb M, Kneitz H, Gelbrich G, Walles H, Mielke S. (2016) Interactions of donor sources and media influence the histomorphological quality of full-thickness skin models. Biotechnol J 11:1352-1361.

Lengfeld J, Buder-Bakhaya K, Goebeler M, Wobser M. (2016) Bisphosphonate-Mediated Oral Ulcers: A Rare Differential Diagnosis of Erosive Oral Lesions. Dermatology 232:117-121.

Lima AL, Karl I, Giner T, Poppe H, Schmidt M, Presser D, Goebeler M, Bauer B. (2016) Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol 174:514-521.

Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, Mueller-Ladner U, Frerix M, Kreuter A, Tigges C, Lahner N, Susok L, Guenther C, Zeidler G, Pfeiffer C, Worm M, Karrer S, Aberer E, Bretterklieber A, Genth E, Simon JC, Distler JH, Hein R, Schneider M, Seitz CS, Herink C, Steinbrink K, Sárdy M, Varga R, Mensing H, Mensing C, Lehmann P, Neeck G, Fiehn C, Weber M, Goebeler M, Burkhardt H, Buslau M, Ahmadi-Simab K, Himsel A, Juche A, Koetter I, Kuhn A, Sticherling M, Hellmich M, Kuhr K, Krieg T, Ehrchen J, Sunderkoetter C, Hunzelmann N, German Network for Systemic Scleroderma (2016) Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients. J Rheumatol 43:66-74.

Müller-Richter UD, Weyandt GH, Woeckel A, Kübler AC. (2016) Vermilion Reconstruction with Genital Mucosa. Plast Reconstr Surg Glob Open 4(5):e701.

Nicolay JP, Wobser M. (2016) Cutaneous B-cell lymphomas - pathogenesis, diagnostic workup, and therapy. J Dtsch Dermatol Ges 14:1207-1224.

Ochsendorf F, Bandholz T, Emmert S, Hartmann K, Hartmann M, Hornung T, Jünger M, Kollewe T, Löser C, Moll I, Psotta-Schachtner C, Spornraft-Ragaller P, Ständer S, von Stebut-Borschitz E, Hamm H. (2016) 111 Top-Lernziele Dermatologie: Lernzielkatalog für Haut- und Geschlechtskrankheiten der Deutschen Dermatologischen Gesellschaft. J Dtsch Dermatol Ges 14:637-43.

Ritter C, Fan K, Paulson KG, Nghiem P, Schrama D, Becker JC. (2016) Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma. Sci Rep 6:21678.

Schmidt M, Goebeler M, Martin SF. (2016) Methods to Investigate the Role of Toll-Like Receptors in Allergic Contact Dermatitis. Methods Mol Biol 1390:319-40.

Schrama D, Hesbacher S, Angermeyer S, Schlosser A, Haferkamp S, Aue A, Adam C, Weber A, Schmidt M, Houben R. (2016) Serine 220 phosphorylation of the Merkel cell polyomavirus Large T antigen crucially supports growth of Merkel cell carcinoma cells. Int J Cancer 138:1153-62.

Stolze I, Trautmann A, Goebeler M, Stoevesandt J. (2016) Dangerous Leg Cramps: Severe Pustular Exanthema Caused by an Over-the-Counter Drug. Acta Derm Venereol 96:703-704.

Sunderkötter C, Feldmeier H, Fölster-Holst R, Geisel B, Klinke-Rehbein S, Nast A, Philipp S, Sachs B, Stingl J, Stoevesandt J, Hamm H. (2016) S1-Leitlinie zur Diagnostik und Therapie der Skabies - Kurzfassung. J Dtsch Dermatol Ges 14:1160-1171.

Thiem A, Kütt S, Hamm H. (2016) 'Television alopecia': a rare cause of pressure alopecia. J Eur Acad Dermatol Venereol 30:504-505.

Thiem A, Mergler R, Kneitz H, Weyandt G, Goebeler M, Gesierich A. (2016) Acne inversa-like skin lesions as a potential adverse event during vemurafenib therapy. J Dtsch Dermatol Ges 14:427-8.

Thomas AC, Zeng Z, Rivière JB, O'Shaughnessy R, Al-Olabi L, St-Onge J, Atherton DJ, Aubert H, Bagazgoitia L, Barbarot S, Bourrat E, Chiaverini C, Chong WK, Duffourd Y, Glover M, Groesser L, Hadj-Rabia S, Hamm H, Happle R, Mushtaq I, Lacour JP, Waelchli R, Wobser M, Vabres P, Patton EE, Kinsler VA. (2016) Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis. J Invest Dermatol 136:770-8.

Trautmann A, Anders D, Stoevesandt J. (2016) H1-Antihistamine Premedication in NSAID-Associated Urticaria. J Allergy Clin Immunol Pract 4:1205-1212.

Trautmann A, Seidl C, Stoevesandt J, Seitz CS. (2016) General anaesthesia-induced anaphylaxis: impact of allergy testing on subsequent anaesthesia. Clin Exp Allergy 46:125-32.

Wiedemann K, Schmid C, Hamm H, Wirbelauer J. (2016) Staphylococcal Scalded Skin Syndrome in a Very Low Birth Weight Premature Infant. Z Geburtshilfe Neonatol 220:25-8.

Willmes C, Kumar R, Becker JC, Fried I, Rachakonda PS, Poppe LM, Hesbacher S, Schadendorf D, Sucker A, Schrama D, Ugurel S. (2016) SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma. Oncotarget 7:10117-32.

Wobser M, Reinartz T, Roth S, Goebeler M, Rosenwald A, Geissinger E. (2016) Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases. Oncol Ther 4:199-210.

Zhu G, Yi X, Haferkamp S, Hesbacher S, Li C, Goebeler M, Gao T, Houben R, Schrama D. (2016) Combination with γ-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cells. Cancer Lett 376:43-52.

Ziegler W, Lempert S, Goebeler M, Kolb-Mäurer A. (2016) Tinea capitis: Erregerspektrum und Epidemiologie im zeitlichen Wandel. J Dtsch Dermatol Ges 14:818-26.

Zimmer L, Goldinger SM, Hofmann L, Loquai C, Ugurel S, Thomas I, Schmidgen MI, Gutzmer R, Utikal JS,  Göppner D, Hassel JC, Meier F, Tietze JK, Forschner A, Weishaupt C, Leverkus M, Wahl R, Dietrich U, Garbe C, Kirchberger MC, Eigentlicher T, Berking C, Gesierich A, Krackhardt AM, Schadendorf D, Schuler G, Dummer R, Heinzerling LM. (2016) Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer 60:210-25.

Publikationen 2015

Bauer B, Trautmann A. (2015) Swollen Ears and Nose Bleeding Accompanied by Skin Papules. Pediatr Dermatol 32:863-4.

Bauer B, Goebeler M, Weissbrich B, Kerstan A. (2015) Kerinokeratosis Papulosa of Childhood. Dermatology 231:1-4.

Behle V, Goebeler M. (2015) Residents'corner April 2015. Seriously saRComa!: Dermatofibrosarcoma protuberans. Eur J Dermatol 25:214.

Behle V, Kneitz H, Goebeler M. (2015) Residents' corner October 2015. Seriously saRComa!: Atypical fibroxanthoma. Eur J Dermatol 25:520-1.

Benoit S, Goebeler M. (2015) Mepacrine in Recalcitrant Cutaneous Lupus Erythematosus: Old-fashioned or Still Useful? Acta Derm Venereol 95:596-9.

Benoit S, Hamm H. (2015) Differenzialdiagnose erosiver und ulzeröser Mundschleimhauterkrankungen im Kindesalter. Hautarzt 66:258-66.

Brenner I, Roth S, Flossbach L, Wobser M, Rosenwald A, Geissinger E. (2015) Lack of MYD88 L265P Mutation in Primary Cutaneous Marginal Zone Lymphoma. Brit J Dermatol 173:1527-1528.

Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, Fuchs T, Jakob T, Lange L, Pfützner W, Mockenhaupt M, Ott H, Pfaar O, Ring J, Sachs B, Sitter H, Trautmann A, Treudler R, Wedi B, Worm M, Wurpts G, Zuberbier T, Merk HF. (2015) Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). Allergo J Int 24:94-105.

Chalmers JR, Wojnarowska F, Kirtschig G, Nunn AJ, Bratton DJ, Mason J, Foster KA, Whitham D, Williams HC; BLISTER study group (Kollaboratoren: u. a. Benoit S). (2015) A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. Br J Dermatol 173:227-34.

Erfle H, Pashayeva K, Harder N, Zhang L, Rohr K, Schadendorf D, Ugurel S, Keese M. (2015) Targeting mitosis-regulating genes in cisplatin-sensitive and -resistant melanoma cells: A live-cell RNAi screen displays differential nucleus-derived phenotypes. Biotechnol J 10:1467-77.

Florence ME, Massuda JY, Soares TC, Stelini RF, Poppe LM, Bröcker EB, Metze K, Cintra ML, de Souza EM. (2015) p53 immunoexpression in stepwise progression of cutaneous squamous cell carcinoma and correlation with angiogenesis and cellular proliferation. Pathol Res Pract 211:782-8.

Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators (Kollaboratoren: u. a. Benoit S). (2015) Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet 386:541-51.

Hamm H, Höger PH. (2015) Nachwuchsprobleme. Hautarzt 66:234-35.

Hill R, Kalathur RK, Colaço L, Brandão R, Ugurel S, Futschik M, Link W. (2015) TRIB2 as a biomarker for diagnosis and progression of melanoma. Carcinogenesis 36:469-77.

Hirose M, Schilf P, Benoit S, Eming R, Gläser R, Homey B, Kunz M, Nebel A, Peitsch WK, Pföhler C, Sárdy M, Schreiber S, Zillikens D, Schmidt E, Ibrahim SM; German AIBD Genetic Study Group. (2015) Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population. Exp Dermatol 24:715-7.

Höger PH, Hamm H. (2015) Psoriasis vulgaris bei Kindern und Jugendlichen. Hautarzt 66:267-76.

Houben R, Angermeyer S, Haferkamp S, Aue A, Goebeler M, Schrama D, Hesbacher S. (2015) Characterization of functional domains in the Merkel cell polyoma virus Large T antigen. Int J Cancer 136:E290-300.

Huth S, Heise R, Vetter-Kauczok CS, Skazik C, Marquardt Y, Czaja K, Knüchel R, Merk HF, Dahl E, Baron JM. (2015) Inter-α-trypsin inhibitor heavy chain 5 (ITIH5) is overexpressed in inflammatory skin diseases and affects epidermal morphology in constitutive knockout mice and murine 3D skin models. Exp Dermatol 24:663-8.

Kneitz H, Mentzel T, Wobser M, Goebeler M. (2015) Kutanes PECom des rechten Unterschenkels. JDDG 13:815-7.

Kneitz H, Motschenbacher S, Wobser M, Goebeler M. (2015) Photoletter to the editor: Giant cutaneous horn associated with squamous cell carcinoma. J Dermatol Case Rep 9:27-8.

Kneitz H, Wobser M, Stoevesandt J, Goebeler M. (2015) Therapieresistente purulente Papeln und Knoten gluteal und im Bereich beider Oberschenkel. Hautarzt 66:636-8.

Kolb-Mäurer A, Goebeler M, Mäurer M. (2015) Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis. Int J Mol Sci 16:14951-60.

Komaravolu RK, Adam C, Moonen JR, Harmsen MC, Goebeler M, Schmidt M. (2015) Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1. Cardiovasc Res 105:86-95.

Leikam C, Hufnagel AL, Otto C, Murphy DJ, Mühling B, Kneitz S, Nanda I, Schmid M, Wagner TU, Haferkamp S, Bröcker EB, Schartl M, Meierjohann S. (2015) In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells. Cell Death Dis 6:e1711.

Lengfeld J, Kneitz H, Goebeler M, Kolb-Mäurer A. (2015) Panniculitis due to pancreatic disease. JDDG 13:807-9.

Moonen JR, Lee ES, Schmidt M, Maleszewska M, Koerts JA, Brouwer LA, van Kooten TG, van Luyn MJ, Zeebregts CJ, Krenning G, Harmsen MC. (2015) Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress. Cardiovasc Res 108:377-86.

Mössner R, Zimmer L, Berking C, Hoeller C, Loquai C, Richtig E, Kähler KC, Hassel JC, Gutzmer R, Ugurel S. (2015) Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literature. J Eur Acad Dermatol Venereol 29:1797-806.

Odongo L, Mulyowa G, Goebeler M, Trautmann A. (2015) Bet v 1- and Bet v 2-Associated Plant Food Sensitization in Uganda and Germany: Differences and Similarities. Int Arch Allergy Immunol 167:264-269.

Poppe H, Kerstan A, Böckers M, Goebeler M, Geissinger E, Rosenwald A, Hamm H. (2015) Childhood mycosis fungoides with a CD8+ CD56+ cytotoxic immunophenotype. J Cutan Pathol 42:258-64.

Recke A, Vidarsson G, Ludwig RJ, Freitag M, Möller S, Vonthein R, Schellenberger J, Haase O, Görg S, Nebel A, Flachsbart F, Schreiber S, Lieb W, Gläser R, Benoit S, Sárdy M, Eming R, Hertl M, Zillikens D, König IR, Schmidt E, Ibrahim S; German AIBD Genetic Study Group. Collaborators (18) Benoit S, Däschlein G, Eming R, Gläser R, Goebeler M, Goetze S, Günther C, Hadaschik E, Homey B, Hunzelmann N, Kreuter A, Kunz M, Lippert U, Ludwig-Peitsch W, Pföhler C, Sárdy M, Sticherling M, Worm M. (2015) Allelic and copy-number variations of FcγRs affect granulocyte function and susceptibility for autoimmune blistering diseases. J Autoimmun 61:36-44.

Schmidt M, Goebeler M. (2015) Immunology of metal allergies. JDDG 13:653-9.

Schmieder A, Poppe M, Hametner C, Meyer-Schraml H, Schaarschmidt ML, Findeisen P, Benoit S, Bauer B, Schmid S, Goebeler M, Goerdt S, Ludwig-Peitsch WK. (2015) Impact of fumaric acid esters on cardiovascular risk factors and depression in psoriasis: a prospective pilot study. Arch Dermatol Res 307:413-24.

Sommer M, Trautmann A, Stoevesandt J. (2015) Relief of photoallergy: atorvastatin replacing simvastatin. J Investig Allergol Clin Immunol 25:138-40.

Stoevesandt J, Hosp C, Kerstan A, Trautmann A. (2015) Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effective. Ann Allergy Asthma Immunol 114:411-6.

Teichert M, Stumpf C, Booken N, Wobser M, Nashan D, Hallermann C, Mogler C, Müller CS, Becker JC, Moritz RK, Andrulis M, Nicolay JP, Goerdt S, Thomas M, Klemke CD, Augustin HG, Felcht M. (2015) Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesis. Exp Dermatol 24:424-9.

Thode C, Woetmann A, Wandall HH, Carlsson MC, Qvortrup K, Kauczok CS, Wobser M, Printzlau A, Odum N, Dabelsteen S. (2015) Malignant T Cells Secrete Galectins and Induce Epidermal Hyperproliferation and Disorganized Stratification in a Skin Model of Cutaneous T Cell Lymphoma. J Invest Dermatol 135:238-246.

Ugurel S, Loquai C, Kähler K, Hassel J, Berking C, Zimmer L, Haubitz I, Satzger I, Müller-Brenne T, Mikhaimer NC, Becker JC, Kilian KJ, Schadendorf D, Heinzerling L, Kaatz M, Utikal J, Göppner D, Pföhler C, Pflugfelder A, Mössner R, Gutzmer R; Dermatologic Cooperative Oncology Group (DeCOG). (2015) A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival. Ann Oncol 26:573-82.

Vaman V S A, Poppe H, Houben R, Grunewald TG, Goebeler M, Butt E. (2015) LASP1, a Newly Identified Melanocytic Protein with a Possible Role in Melanin Release, but Not in Melanoma Progression. PLoS One 10:e0129219.

Wobser M, Bauer B, Goebeler M. (2015) Subcutaneous nodule on the scrotum. J Dtsch Dermatol Ges 13:165-7.

Wobser M, Ernestus K, Hamm H. (2015) Pediatric dermatohistopathology - histopathology of skin diseases in newborns and infants. J Dtsch Dermatol Ges 13:535-48.

Wobser M, Roth S, Reinartz T, Rosenwald A, Goebeler M, Geissinger E. (2015) CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas. Br J Dermatol 172:1573-80.

Zeller S, Lempert S, Goebeler M, Hamm H, Kolb-Mäurer A. (2015) Cladosporium cladosporioides: a so far unidentified cause of white piedra. Mycoses 58:315-7.

Zörnig I, Halama N, Lorenzo Bermejo J, Ziegelmeier C, Dickes E, Migdoll A, Kaiser I, Waterboer T, Pawlita M, Grabe N, Ugurel S, Schadendorf D, Falk C, Eichmüller SB, Jäger D. (2015) Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients. Int J Cancer 136:138-5.

Publikationen 2014

Adam C, Baeurle A, Brodsky JL, Wipf P, Schrama D, Becker JC, Houben R. (2014) The HSP70 Modulator MAL3-101 Inhibits Merkel Cell Carcinoma. PLoS ONE 9:e92041.

Aigner B, Ugurel S, Kaddu S, Becker JC. Kutane Sarkome. (2014) Update ausgewählter Entitäten fibrohistiozytärer und myofibrozytärer Morphologie. Hautarzt 65:614-622.

Angermeyer S, Hesbacher S, Becker JC, Schrama D, Houben R. (2014) Response to Shuda et al. J Invest Dermatol 134:1481-2.

Behle V, Hamm H. (2014) Developmental abnormalities and nevi of the scalp. Hautarzt 65:1022-9.

Behr DS, Peitsch WK, Hametner C, Lasitschka F, Houben R, Schönhaar K, Michel J, Dollt C, Goebeler M, Marx A, Goerdt S, Schmieder A. (2014) Prognostic value of immune cell infiltration, tertiary lymphoid structures and pd-l1 expression in Merkel cell carcinomas. Int J Clin Exp Pathol 7:7610-21.

Benoit S, Goebeler M. (2014) Vasculitis in childhood - a dermatological approach. J Dtsch Dermatol Ges 12:124-9.

Benoit S, Schlipf N, Hausser I, Fischer J, Hamm H. (2014) White Sponge Nevus - A Rare Autosomal Dominant Keratinopathy. Klin Padiatr 226:375-376.

Brasch J, Becker D, Aberer W, Bircher A, Kränke B, Jung K, Przybilla B, Biedermann T, Werfel T, John SM, Elsner P, Diepgen T, Trautmann A, Merk HF, Fuchs T, Schnuch A. (2014) Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKI), the Working Group for Occupational and Environmental Dermatology (ABD) of the DDG, the Medical Association of German Allergologists (AeDA), the Professional Association of German Dermatologists (BVDD) and the DDG. Allergo J Int 23:126-138.

Buder K, Hamm H. (2014) Residents' corner October 2014. Nail it! A bleeding tumour at the fingertip. Eur J Dermatol 24:637-8.

Buder K, Hamm H. Residents' corner April 2014. (2014) Nail it!: eye-catching nail folds. Eur J Dermatol 24:283-4.

Buder K, Lapa C, Kreissl MC, Schirbel A, Herrmann K, Schnack A, Bröcker EB, Goebeler M, Buck AK, Becker JC. (2014) Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging. BMC Cancer 14:268.

Buder K, Ruppert S, Trautmann A, Bröcker E-B, Goebeler M, Kerstan A. (2014) Angiolymphoide Hyperplasie mit Eosinophilie und Morbus Kimura - ein klinischer und histopathologischer Vergleich. J Dtsch Dermatol Ges 12:224-8.

Buder K, Müller PA, Beckmann G, Ugurel S, Bröcker EB, Becker JC. (2014) Denileukin Diftitox plus total skin electron beam radiation in patients with treatment-refractory cutaneous T-cell lymphoma (Mycosis fungoides): report of four cases. Acta Derm Venereol 94:94-96.

Chandran PA, Keller A, Weinmann L, Seida AA, Braun M, Andreev K, Fischer B, Horn E, Schwinn S, Junker M, Houben R, Dombrowski Y, Dietl J, Finotto S, Wölfl M, Meister G, Wischhusen J. (2014) The TGF-β-inducible miR-23a cluster attenuates IFN-γ levels and antigen-specific cytotoxicity in human CD8⁺T cells. J Leukoc Biol 96:633-45.

Fredholm S, Gjerdrum LM, Willerslev-Olsen A, Petersen DL, Nielsen IØ, Kauczok CS, Wobser M, Ralfkiaer U, Bonefeld CM, Wasik MA, Krejsgaard T, Geisler C, Ralfkiaer E, Gniadecki R, Woetmann A, Odum N. (2014) STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides. Anticancer Res 34:5277-86.

Gerstner S, Kneitz H, Bröcker EB, Trautmann A. (2014) Differentialdiagnose Angioödem. Akut ödematöses Skleromyxödem. Hautarzt 65:454-7.

Goldinger SM, Zimmer L, Schulz C, Ugurel S, Hoeller C, Kaehler KC, Schadendorf D, Hassel JC, Becker J, Hauschild A, Dummer R; Dermatology Cooperative Oncology Group (DeCOG). (2014) Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients. Eur J Cancer 50:406-10.

Gutzmer R, Hassel JC, Kähler KC, Loquai C, Mössner R, Ugurel S, Zimmer L, für das Komitee "Kutane Nebenwirkungen" der ADO (2014) Kutane Nebenwirkungen der medikamentösen Tumortherapie mit BRAF- und MEK-Inhibitoren. Hautarzt 65:582-89.

Hamm H, Wolff H. (2014) Blickpunkt Kopfhaut. Hautarzt 65:1020-1.

Hamm, H. (2014) Impact of Hyperhidrosis on Quality of Life and its Assessment. Dermatol Clin 32:467-76.

Havlickova B, Weyandt GH. (2014) Therapeutic management of anal eczema: an evidence-based review. Int J Clin Pract 68:1388-99.

Heiduschka G, Lill C, Seemann R, Brunner M, Schmid R, Houben R, Bigenzahn J, Thurnher D. (2014) The effect of resveratrol in combination with irradiation and chemotherapy. Strahlenther Onkol 190:75-80.

Höger PH, Hamm H. (2014) Psoriasis vulgaris bei Kinder und Jugendlichen. Monatsschr Kinderheilkd 162:163-77.

Houben R, Schmid CP, Maier M, Wobser M, Motschenbacher S, Becker JC, Vetter-Kauczok CS, Weyandt G, Hesbacher S, Haferkamp S. (2014) p53 Regulation by TRP2 Is Not Pervasive in Melanoma. PLoS ONE 9:e87440.

Humbert P, Faivre B, Véran Y, Debure C, Truchetet F, Bécherel PA, Plantin P, Kerihuel JC, Eming SA, Dissemond J, Weyandt G, Kaspar D, Smola H, Zöllner P, the CLEANSITE study group (2014) Protease-modulating polyacrylate-based hydrogel stimulates wound bed preparation in venous leg ulcers - a randomized controlled trial. J Eur Acad Dermatol Venereol 28:1742-50.

Karademir F, Kerstan A, Hamm H. (2014) Anetodermisches Pilomatrikom. Seltene Variante eines häufigen Adnextumors im Kindesalter. Hautarzt 65:59-62.

Karl I, Jossberger-Werner M, Schmidt N, Horn S, Goebeler M, Leverkus M, Wajant H, Giner T. (2014) TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis. Cell Death Dis 5:e1444.

Kolb-Mäurer A, Betz RC, Hamm H. (2014) Odd-Looking Hair and Progressive Alopecia in Mother and Son. JAMA Dermatol 150:567-8.

Kuhn A, Sigges J, Biazar C, Ruland V, Patsinakidis N, Landmann A, Amler S, Bonsmann G; The EUSCLE Co-Authors (u. a. Benoit S, Bröcker E). (2014) Influence of Smoking on Disease Severity and Antimalarial Therapy in Cutaneous Lupus Erythematosus: Analysis of 1002 Patients from the EUSCLE Database. Br J Dermatol 171:571-9.

Leufke C, Leykauf J, Krunic D, Jauch A, Holtgreve-Grez, Böhm-Steuer B, Bröcker E-B, Mauch C, Utikal J, Hartschuh W, Purdie KJ, Boukamp P. (2014) The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas. Oncogene 33:3506-18.

Paulson KG, Tegeder A, Willmes C, Iyer JG, Afanasiev OK, Schrama D, Koba S, Thibodeau R, Nagase K, Simonson WT, Seo A, Koelle DM, Madeleine MM, Bhatia S, Nakajima H, Sano S, Hardwick J, Disis ML, Cleary MA, Becker JC, Nghiem P. (2014) Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma. Cancer Immunol Res 2:1071-9.

Schrama D, Groesser L, Ugurel S, Hafner C, Pastrana DV, Buck CB, Cerroni L, Theiler A, Becker JC. (2014) Presence of Human Polyomavirus 6 in Mutation-Specific BRAF Inhibitor-Induced Epithelial Proliferations. JAMA Dermatol 150:1180-6.

Schrama D, Ugurel S, Sucker A, Ritter C, Zapatka M, Schadendorf D, Becker JC. (2014) STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients. Front Med (Lausanne) 1:47.

Seitz CS, Brockow K, Hain J, Trautmann A. (2014) Non-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase? Allergy Asthma Clin Immunol 10:19.

Starke J, Wehrle-Haller B, Friedl P. (2014) Plasticity of the actin cytoskeleton in response to extracellular matrix nanostructure and dimensionality. Biochem Soc Trans. 42:1356-66.

Stoevesandt J, Hain J, Stolze I, Kerstan A, Trautmann A. (2014) Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy buildup phase. Clin Exp Allergy 44:747-55.

Stoevesandt J, Hosp C, Kerstan A, Trautmann A. (2014) Risikostratifizierung systemischer allergischer Reaktionen während Einleitung der spezifischen Immuntherapie mit Bienen- und Wespengift. J Dtsch Dermatol Ges 12:244-56.

Trautmann A, Seitz CS, Stoevesandt J, Kerstan A. (2014) Aminopenicillin-associated exanthem: lymphocyte transformation testing revisited. Clin Exp Allergy 44:1531-8.

Ugurel S, Mentzel T, Utikal J, Helmbold P, Mohr P, Pföhler C, Schiller M, Hauschild A, Hein R, Kämpgen E, Kellner I, Leverkus M, Becker JC, Ströbel P, Schadendorf D. (2014) Neo-adjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase-II DeCOG trial with long-term follow-up. Clin Cancer Res 20:499-510.

Van Allen EM, Wagle N, Sucker A, Treacy DJ, Johannessen CM, Goetz EM, Place CS, Taylor-Weiner A, Whittaker S, Kryukov GV, Hodis E, Rosenberg M, McKenna A, Cibulskis K, Farlow D, Zimmer L, Hillen U, Gutzmer R, Goldinger SM, Ugurel S, Gogas HJ, Egberts F, Berking C, Trefzer U, Loquai C, Weide B, Hassel JC, Gabriel SB, Carter SL, Getz G, Garraway LA, Schadendorf D; Dermatologic Cooperative Oncology Group of Germany (DeCOG). (2014) The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma. Cancer Discov 4:94-109.

Waldenburger S, Vogel U, Goebeler M, Kolb-Mäurer A. (2014) Ambulant erworbene Hautinfektionen durch Staphylococcus aureus: spielt das Toxin Panton-Valentine-Leukozidin eine Rolle? J Dtsch Dermatol Ges 12:59-67.

Weishaupt J, Kolb-Mäurer A, Lempert S, Nenoff P, Uhrlaß S, Hamm H, Goebeler M. (2014) A different kind of hedgehog pathway: tinea manus due to Trichophyton erinacei transmitted by an African pygmy hedgehog (Atelerix albiventris). Mycoses 57:125-7.

Wieshuber C, Stoevesandt J, Trautmann A. (2014) The needle in the haystack: allergic anaphylaxis caused by the local anesthetic articaine. Eur Ann Allergy Clin Immunol 46:38-40.

Wobser M, Hamm H. (2014) Teleangiectasia macularis eruptiva perstans with congenital onset in a 5-year-old girl. Clin Dermatol 2:144-146.

Kontakt, Öffnungszeiten, Sprechzeiten

Terminvereinbarung Poliklinik:

Tel. +49 931 201-26714

Montag bis Donnerstag
08:00 Uhr bis 10:00 Uhr und
13:00 Uhr bis 16:00 Uhr

Freitag
08:00 Uhr bis 10:00 Uhr und
13:00 Uhr bis 15:00 Uhr

Terminvereinbarung Privatambulanz:

Montag bis Freitag
8:00 Uhr bis 12:00 Uhr

Margit Körner
Tel. +49 931 201-26354

Telefon:

Pforte:
+49 931 201-26710

Direktor:
Prof. Dr. med. Matthias Goebeler

Sekretariat:
Gudrun Braun
+49 931 201-26351

Studierendenangelegenheiten:
Ute Düchs
+49 931 201-26353

E-Mail:
info-hautklinik@ ukw.de

Fax:
+49 931 201-26700


Anschrift:

Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie | Josef-Schneider-Str. 2 | Haus D8 | 97080 Würzburg | Deutschland